172 related articles for article (PubMed ID: 27905500)
21. Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance.
Cheng YS; Sacchettini JC
Biochemistry; 2016 Feb; 55(7):1107-19. PubMed ID: 26848874
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the role of para-aminobenzoic acid biosynthesis in folate production by Lactococcus lactis.
Wegkamp A; van Oorschot W; de Vos WM; Smid EJ
Appl Environ Microbiol; 2007 Apr; 73(8):2673-81. PubMed ID: 17308179
[TBL] [Abstract][Full Text] [Related]
23. Promoter strength of folic acid synthesis genes affects sulfa drug resistance in Saccharomyces cerevisiae.
Iliades P; Berglez J; Meshnick S; Macreadie I
Microb Drug Resist; 2003; 9(3):249-55. PubMed ID: 12959403
[TBL] [Abstract][Full Text] [Related]
24. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Assaraf YG
Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
[TBL] [Abstract][Full Text] [Related]
25. para-Aminobenzoic acid is a precursor in coenzyme Q6 biosynthesis in Saccharomyces cerevisiae.
Marbois B; Xie LX; Choi S; Hirano K; Hyman K; Clarke CF
J Biol Chem; 2010 Sep; 285(36):27827-38. PubMed ID: 20592037
[TBL] [Abstract][Full Text] [Related]
26. Anti-folates potentiate bactericidal effects of other antimicrobial agents.
Li K; Wang XD; Yang SS; Gu J; Deng JY; Zhang XE
J Antibiot (Tokyo); 2017 Mar; 70(3):285-291. PubMed ID: 28074051
[TBL] [Abstract][Full Text] [Related]
27. Bacterial conversion of folinic acid is required for antifolate resistance.
Ogwang S; Nguyen HT; Sherman M; Bajaksouzian S; Jacobs MR; Boom WH; Zhang GF; Nguyen L
J Biol Chem; 2011 Apr; 286(17):15377-90. PubMed ID: 21372133
[TBL] [Abstract][Full Text] [Related]
28. Herbicidal effects of sulfamethoxazole in Lemna gibba: using p-aminobenzoic acid as a biomarker of effect.
Brain RA; Ramirez AJ; Fulton BA; Chambliss CK; Brooks BW
Environ Sci Technol; 2008 Dec; 42(23):8965-70. PubMed ID: 19192826
[TBL] [Abstract][Full Text] [Related]
29. [Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis].
Zhang ZD; Zhao YL; Li ZH; Jia HY; Liu YH; Chen X; Liu ZQ; Du BP; Xing AY; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):683-5. PubMed ID: 18070553
[TBL] [Abstract][Full Text] [Related]
30. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
[TBL] [Abstract][Full Text] [Related]
31. Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to
Yu JF; Xu JT; Yang SS; Gao MN; Si HR; Xiong DY; Gu J; Wu ZL; Zhou J; Deng JY
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0146521. PubMed ID: 34780266
[TBL] [Abstract][Full Text] [Related]
32. Drug evolution: p-aminobenzoic acid as a building block.
Kluczyk A; Popek T; Kiyota T; de Macedo P; Stefanowicz P; Lazar C; Konishi Y
Curr Med Chem; 2002 Nov; 9(21):1871-92. PubMed ID: 12369873
[TBL] [Abstract][Full Text] [Related]
33. Biochemical and genetic characterization of an early step in a novel pathway for the biosynthesis of aromatic amino acids and p-aminobenzoic acid in the archaeon Methanococcus maripaludis.
Porat I; Sieprawska-Lupa M; Teng Q; Bohanon FJ; White RH; Whitman WB
Mol Microbiol; 2006 Nov; 62(4):1117-31. PubMed ID: 17010158
[TBL] [Abstract][Full Text] [Related]
34. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
35. Small Molecule Efflux Pump Inhibitors in Mycobacterium tuberculosis: A Rational Drug Design Perspective.
Kapp E; Malan SF; Joubert J; Sampson SL
Mini Rev Med Chem; 2018; 18(1):72-86. PubMed ID: 28494730
[TBL] [Abstract][Full Text] [Related]
36. ubiA (Rv3806c) encoding DPPR synthase involved in cell wall synthesis is associated with ethambutol resistance in Mycobacterium tuberculosis.
He L; Wang X; Cui P; Jin J; Chen J; Zhang W; Zhang Y
Tuberculosis (Edinb); 2015 Mar; 95(2):149-54. PubMed ID: 25547657
[TBL] [Abstract][Full Text] [Related]
37. Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
Rosen BC; Dillon NA; Peterson ND; Minato Y; Baughn AD
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855077
[TBL] [Abstract][Full Text] [Related]
38. Mycobacterium sulfur metabolism and implications for novel drug targets.
Zeng L; Shi T; Zhao Q; Xie J
Cell Biochem Biophys; 2013 Mar; 65(2):77-83. PubMed ID: 23054909
[TBL] [Abstract][Full Text] [Related]
39. Folate biosynthesis pathway: mechanisms and insights into drug design for infectious diseases.
Bertacine Dias MV; Santos JC; Libreros-Zúñiga GA; Ribeiro JA; Chavez-Pacheco SM
Future Med Chem; 2018 Apr; 10(8):935-959. PubMed ID: 29629843
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of the antimicrobial drug trimethoprim revisited.
Quinlivan EP; McPartlin J; Weir DG; Scott J
FASEB J; 2000 Dec; 14(15):2519-24. PubMed ID: 11099470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
